Table 1 Background patient characteristics between patients with Gleason score ≤ 6 (HRLGH) and Gleason score ≥ 7 (HRHG).

From: The influence of Gleason score ≤ 6 histology on the outcome of high-risk localized prostate cancer after modern radiotherapy

Variables

Strata

HRLG

HRHG

p-value

No. (%) or median [range]

No. (%) or median [range]

(n = 94)

(n = 1125)

Age

 

71 [54, 86]

70.3 [48, 86]

0.878

Gleason score

5

8 (8.5)

0 (0.0)

 < 0.001

6

86 (91.5)

0 (0.0)

 

7

0 (0.0)

426 (37.9)

 

8 ≤ 

0 (0.0)

699 (62.1)

 

ADT

No

10 (10.6)

68 (6.0)

0.119

Yes

84 (89.4)

1057 (94.0)

 

Modality (%)

HDR + EBRT

61 (64.9)

855 (76.0)

 < 0.001

IMRT

21 (22.3)

176 (15.6)

 

LDR ± EBRT

11 (11.7)

28 (2.5)

 

SBRT

1 (1.1)

66 (5.9)

 

iPSA

ng/ml

20.26 [4.55, 107]

17.40 [2.68, 1454]

0.697

T category

1

14 (14.9)

149 (13.2)

0.828

2

31 (33.0)

372 (33.1)

 

3

48 (51.1)

595 (52.9)

 

4

1 (1.1)

9 (0.8)

 
  1. iPSA = initial PSA value, % of HRLG in BT ± EBRT and EBRT = 7.5% and 8.3% (p = 0.696).
  2. Significant values are in bold.